February 18, 2009 – GE Healthcare said the new Discovery PET/CT 600-series scanners, designed to help enable earlier detection and accurate monitoring of disease, are being installed globally.

The first clinical installs will be completed at: Miami Baptist Hospital in Florida; University Hospital of Bichat in Paris, France; Queensland X-Ray at the Mater Hospital in Brisbane, Australia; Duke University Medical Center in North Carolina; and Mayo Clinic in Minnesota.

The new PET/CT platform was built based on clinician needs for more power to explore the potential of PET/CT imaging that includes better PET quantitative accuracy, according to GE. This new line of PET/CT scanners, combine advanced molecular imaging tools with the large coverage low dose Volume CT helping allow for earlier diagnosis, more accurate tumor location and better assessment of how a patient is responding to cancer treatment. Although mostly for use in oncology, PET/CT can also be used for assisting the diagnosis of cardiovascular disease and neurological conditions.

The new system leverages the high-speed, high-resolution capabilities of GE’s advanced CT, the LightSpeed VCT. Volume CT technology, with 40 mm of coverage, reduces CT acquisition times and CT dose. Static organs can be imaged in as little as one second, the lung in as little as two seconds and a whole body trauma could be performed in less than 10 seconds.

GE's next generation of MotionFree imaging technologies are introduced in the new Discovery 600 series PET/CT, giving clinicians detailed images even in areas of the body subject to movement caused by respiration. GE's MotionFree imaging technologies are integrated with VUE Point FX, an advanced high-definition reconstruction technique. Combined, these technologies have the potential to improve small lesion detection, image quality, and better therapy response monitoring.

By combining the LightSpeed VCT with the breakthrough motion management capabilities of the Discovery PET system, the new Discovery PET/CT platform provides the next evolution PET/CT system, bringing clinically-relevant innovations designed to open doors to new and advanced procedure possibilities in non-invasive diagnostic imaging.

For more information: www.gehealthcare.com


Related Content

News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 18, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | FDA

June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...

Time June 10, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Cardiac Imaging

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...

Time April 23, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Radiology Business

December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...

Time December 27, 2023
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
Subscribe Now